This entry was posted on Tuesday, October 20th, 2009 at 10:39 am and is filed under Mercury Related, Vaccine news. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
By now most of us are familiar with H1N1 influenza, colloquially known as swine flu, a respiratory condition that has besieged many workplaces and a few universities as well. The flu is still relatively new to the American public, as it was first identified in spring of this year. H1N1 is particularly troublesome because of how quickly and easily it can spread from one person to another.
A vaccine has been formulated and made available to the public for the 2009-10 fuel season, which lasts until next May. The vaccine purports to prevent the following flu symptoms: fever, sore throat, muscle aches, fatigue, diarrhea, vomiting. If infected, most individuals experience flu-like symptoms for eight days. Although the Centers for Disease Control would have us believe that flu vaccines are safe, it’s important to weigh the benefits and drawbacks.
The H1N1 vaccine does contain thimerosal, a mercury-based preservative that has been linked in some studies to the onset of autism in young children. Anyone who has read about or experienced the effects of mercury poisoning knows how harmful that toxic metal can be when it’s unleashed on human tissue. The Mayo Clinic recommends the following swine flu prevention options: stay home when you’re sick, wash your hands regularly and avoid contact with crowds.
12 Responses to “Thimerosal Rears Its Ugly Head”
Leave a Reply
You must be logged in to post a comment.